Medpace Holdings, Inc.
DE ˙ DB ˙ US58506Q1094
€ 394,00 ↑6.10 (1.57%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:01P / Medpace Holdings, Inc.
InstitutionWasatch Advisors Inc
Wasatch Advisors Inc ownership in 01P / Medpace Holdings, Inc.
Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2024-02-09 2024-02-09 13G/A
2023-02-08 2023-02-08 13G/A
2022-02-11 2022-02-11 13G/A
2021-02-11 2021-02-11 13G/A
2020-02-10 2020-02-10 13G

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F MEDPACE HLDGS COM 58506Q109 773,931 125,625 19.38 371,634 2.06 2.4679
2026-02-12 2025-12-31 13F MEDPACE HLDGS COM 58506Q109 648,306 -277,657 -29.99 364,121 -23.52
2025-11-14 2025-09-30 13F MEDPACE HLDGS COM 58506Q109 925,963 -19,851 -2.10 476,093 60.38 2.5615
2025-08-14 2025-06-30 13F MEDPACE HLDGS COM 58506Q109 945,814 116,354 14.03 296,853 17.46 1.5541
2025-05-15 2025-03-31 13F MEDPACE HLDGS COM 58506Q109 829,460 -107,382 -11.46 252,728 -18.80 1.4100
2025-02-13 2024-12-31 13F MEDPACE HLDGS COM 58506Q109 936,842 28,161 3.10 311,247 2.61 1.5409
2024-11-14 2024-09-30 13F MEDPACE HLDGS COM 58506Q109 908,681 -58,602 -6.06 303,318 -23.86 1.4866
2024-08-14 2024-06-30 13F MEDPACE HLDGS COM 58506Q109 967,283 -7,132 -0.73 398,376 1.16 2.1308
2024-04-18 2024-03-31 13F MEDPACE HLDGS COM 58506Q109 974,415 -211,766 -17.85 393,810 8.31 2.0595
2024-02-14 2023-12-31 13F MEDPACE HLDGS COM 58506Q109 1,186,181 -85,655 -6.73 363,600 18.07 2.0029
2023-11-14 2023-09-30 13F MEDPACE HLDGS COM 58506Q109 1,271,836 -297,065 -18.93 307,950 -18.27 1.9458
2023-08-08 2023-06-30 13F MEDPACE HLDGS COM 58506Q109 1,568,901 -289,753 -15.59 376,803 7.81 2.2812
2023-05-12 2023-03-31 13F MEDPACE HLDGS COM 58506Q109 1,858,654 220,836 13.48 349,520 0.47 2.1759
2023-02-14 2022-12-31 13F MEDPACE HLDGS COM 58506Q109 1,637,818 -517,688 -24.02 347,889 2.69 2.3415
2022-11-14 2022-09-30 13F MEDPACE HLDGS COM 58506Q109 2,155,506 -217,717 -9.17 338,781 -4.62 2.3540
2022-08-12 2022-06-30 13F MEDPACE HLDGS COM 58506Q109 2,373,223 -355,169 -13.02 355,200 -20.42 2.2455
2022-05-13 2022-03-31 13F MEDPACE HLDGS COM 58506Q109 2,728,392 294,103 12.08 446,338 -15.75 2.1973
2022-02-15 2021-12-31 13F Medpace Holdings COM 58506Q109 2,434,289 -61,773 -2.47 529,799 12.14 2.1612
2021-11-12 2021-09-30 13F MEDPACE HLDGS COM 58506Q109 2,496,062 46,770 1.91 472,455 9.21 1.9200
2021-08-12 2021-06-30 13F MEDPACE HLDGS COM 58506Q109 2,449,292 -204,694 -7.71 432,618 -0.64 1.7562
2021-05-10 2021-03-31 13F MEDPACE HLDGS COM 58506Q109 2,653,986 -187,008 -6.58 435,386 10.09 1.9550
2021-02-12 2020-12-31 13F MEDPACE HLDGS COM 58506Q109 2,840,994 570,266 25.11 395,467 55.85 1.9463
2020-11-10 2020-09-30 13F MEDPACE HLDGS COM 58506Q109 2,270,728 -290,275 -11.33 253,754 6.52 1.6139
2020-08-12 2020-06-30 13F MEDPACE HLDGS COM 58506Q109 2,561,003 270,621 11.82 238,224 41.74 1.7235
2020-05-08 2020-03-31 13F MEDPACE HLDGS COM 58506Q109 2,290,382 485,397 26.89 168,068 10.77 1.7499
2020-02-13 2019-12-31 13F MEDPACE HLDGS COM 58506Q109 1,804,985 398,775 28.36 151,727 28.39 1.2442
2019-11-14 2019-09-30 13F MEDPACE HLDGS COM 58506Q109 1,406,210 -598,917 -29.87 118,178 -9.91 1.1260
2019-08-07 2019-06-30 13F MEDPACE HLDGS COM 58506Q109 2,005,127 600,686 42.77 131,175 58.39 1.2779
2019-05-08 2019-03-31 13F MEDPACE HLDGS COM 58506Q109 1,404,441 209,449 17.53 82,820 30.94 0.9026
2019-02-14 2018-12-31 13F MEDPACE HLDGS COM 58506Q109 1,194,992 1,194,992 63,251 0.8430
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.